# Hospira Inc – FDA Inspection, Jun 7, 2024

Source: https://www.keypedia.com/records/fda_inspections/hospira-inc/251b750d-e7dd-4072-b32a-338d73b69de8
Source feed: FDA_Inspections

> FDA inspection 1241064 of Hospira Inc, June 07, 2024. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241064
- Company Name: Hospira Inc
- Inspection Date: 2024-06-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1278254 - 2025-08-22
- FDA Inspection 1121881 - 2020-02-27
- FDA Inspection 919379 - 2015-04-13
- FDA Inspection 906256 - 2014-12-09
- FDA Inspection 846706 - 2013-09-09

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.keypedia.com/companies/hospira-inc/289dd5d3-2a33-49a2-bcf1-61d983a83d50

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d